may be a supportive part of care when adapted for fatigue, cognition, neuropsychiatric symptoms, and post-exertional limits.
Evidence
Review synthesizes long-COVID and ME/CFS evidence, management principles, and CBT trials, including moderate-certainty evidence for reduced fatigue and improved cognitive function.
Caveat
The review notes heterogeneous definitions and interventions, no established biomarkers or disease-modifying treatments, and the need to avoid treating the illness as primarily psychological.
Simplified
BACKGROUND: presents a spectrum of persistent symptoms that substantially overlap with (ME/CFS), including debilitating fatigue, post-exertional malaise, cognitive dysfunction, and neuropsychiatric manifestations. Despite growing evidence of shared pathophysiological mechanisms, neither condition has established diagnostic biomarkers or disease-modifying treatments. (CBT), when appropriately implemented, may serve as one component of comprehensive care. This review examines the neuropsychiatric manifestations, management principles, and implementation considerations for CBT in long COVID, drawing insights from ME/CFS experience.
MAIN BODY: Our analyses revealed substantial overlap between patients with long COVID and ME/CFS including immune dysregulation, neuroinflammation, and metabolic dysfunction while identifying distinct features in disease trajectories. Evidence suggests ME/CFS may represent a severe phenotype in a subset of patients with long COVID. Management principles applicable to both conditions include patient validation, comprehensive needs assessment, individualized energy management, symptom-specific interventions, and comorbidity management. Current clinical trials demonstrate methodological evolution in CBT implementation, from traditional protocols to digital platforms. Moderate-certainty evidence indicates CBT may reduce fatigue and improve cognitive function in long COVID. However, substantial heterogeneity exists in both intervention characteristics and condition definitions. Implementation success requires provider competency, terminological precision, and individualized approaches that respect energy limitations. Careful monitoring for post-exertional symptom exacerbation is essential. We emphasize that these approaches do not imply these conditions are primarily psychological.
CONCLUSION: Our review synthesizes current evidence on CBT in long COVID management, considering lessons from ME/CFS. Substantial challenges remain in standardizing terminology, strengthening trial methodology, and determining optimal implementation strategies. Future research should incorporate objective outcome measures alongside subjective reports, while clinical practice should consider how cognitive-behavioral approaches might contribute to comprehensive care plans tailored to individual patient needs. This approach recognizes that addressing both physical and psychological dimensions of these conditions may enhance treatment outcomes, while acknowledging the individualized nature of patient responses to different therapeutic elements.
Key numbers
58% of individuals
Prevalence of ME/CFS Criteria Fulfillment
Among individuals with evaluated approximately 70 weeks post-infection.
4.32 times
Risk for Chronic Fatigue
Compared to pre-COVID-19 fatigue levels.
mean difference −8.4
Reduction in Fatigue with
In individuals with .
Full Text
We can’t show the full text here under this license.
